stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
무료 - Play StoreApp Store
설치하다설치하다
logo
Teva Pharmaceutical Industries Ltd AdrTEVA
$42.391.15%0.48
시간 외 거래: 42.15-0.24 -0.57%

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Date: 2026-11-04 16:00O: 41.89H: 42.59L: 41.29C: 41.80Vol: 8.537M
전일 마감가:
$41.91
열려 있는:
$41.89
하루 거래량:
2,515,817
상대 거래량:
0.38
시가총액:
$49.44B
수익:
$17.53B
순이익/손실:
$1.58B
주가수익비율:
31.50
EPS:
$1.35
순현금흐름:
$444.18M
1W 성능:
+6.05%
1M 성능:
+7.24%
6M 성능:
+19.92%
1Y 성능:
+107.18%
1일 변동 폭
$41.29$42.41
1주일 범위
$40.01$43.34
52주 변동 폭
$20.11$43.34

Teva Pharmaceutical Industries Ltd Adr 주식 (TEVA) 회사 개요

명칭
Teva Pharmaceutical Industries Ltd Adr
전화
972 (3) 914-8213
주소
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV, Israel
직원
33,346
다음 수익 날짜
null
최신 SEC 제출 서류
SEC
X에서 TEVA에 대한 토론
X

 

시가총액

 

매출

 

순이익

 

현금흐름

 

주당 순 이익

 

Teva Pharmaceutical Industries Ltd Adr 주식(TEVA) 업그레이드 및 다운그레이드

날짜액션분석자등급 변경
2026-10-01개시TD CowenBuy
2026-09-23개시OppenheimerOutperform
2026-09-09개시Leerink PartnersOutperform
2025-12-09개시BarclaysOverweight

Teva Pharmaceutical Industries Ltd Adr (TEVA) 재무 분석

기간추세FY 2025FY 2024FY 2023FY 2022FY 2021
기간 종료일2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)17,258.0016,544.0015,846.0014,925.0015,878.00
Cost of revenue USD (M)8,320.008,481.008,200.007,952.008,284.00
Gross profit USD (M)8,938.008,064.007,645.006,973.007,594.00
Research and development USD (M)---98.00-
Operating expenses USD (M)--7,212.009,072.005,878.00
Operating income USD (M)2,157.00-303.00433.00-2,099.001,716.00
Income before tax USD (M)1,223.00-1,284.00-624.00-3,065.00658.00
Income tax expense USD (M)-180.00676.00-7.00-638.00211.00
Net income USD (M)1,418.00-1,959.00-615.00-2,406.00456.00
Basic EPS USD/shares1.23-1.45-0.50-2.120.38
Diluted EPS USD/shares1.21-1.45-0.50-2.120.38
Basic weighted shares shares (M)1,145.001,131.001,119.001,110.001,102.00
Diluted weighted shares shares (M)1,163.001,131.001,119.001,110.001,107.00

Teva Pharmaceutical Industries Ltd Adr 주식 (TEVA) 내부자 거래

  • Shareholder
    거래
    Proposed Sale
    비용
    $39.19
    #주식
    367,600
    가치 ($)
    14,406,244
    #주식 총계
    0
  • Savage BrianSep 18 '26
    Interim Chief Legal Officer
    거래
    Option Exercise
    비용
    $34.70
    #주식
    4,503
    가치 ($)
    156,254
    #주식 총계
    15,842
  • Savage BrianSep 18 '26
    Interim Chief Legal Officer
    거래
    Sale
    비용
    $38.85
    #주식
    7,342
    가치 ($)
    285,215
    #주식 총계
    8,500
  • MIGNONE ROBERTOSep 18 '26
    Director
    거래
    Sale
    비용
    $39.06
    #주식
    367,600
    가치 ($)
    14,356,802
    #주식 총계
    0
  • Savage BrianSep 18 '26
    Officer
    거래
    Proposed Sale
    비용
    $38.85
    #주식
    7,028
    가치 ($)
    273,062
    #주식 총계
    0
  • Weiss AmirAug 21 '26
    Chief Accounting Officer
    거래
    Sale
    비용
    $37.62
    #주식
    9,445
    가치 ($)
    355,301
    #주식 총계
    13,071
  • Weiss AmirAug 21 '26
    Chief Accounting Officer
    거래
    Option Exercise
    비용
    $19.61
    #주식
    2,500
    가치 ($)
    49,025
    #주식 총계
    15,571
  • Director
    거래
    Sale
    비용
    $37.25
    #주식
    415
    가치 ($)
    15,459
    #주식 총계
    111,986
  • Lippman EvanAug 17 '26
    Officer
    거래
    Proposed Sale
    비용
    $36.57
    #주식
    18,600
    가치 ($)
    680,291
    #주식 총계
    0
  • Lippman EvanAug 17 '26
    EVP, Business Development
    거래
    Sale
    비용
    $36.57
    #주식
    18,600
    가치 ($)
    680,291
    #주식 총계
    25,591
내부자 거래관계날짜거래비용#주식가치 ($)#주식 총계
Bridger Management, LLC (1)ShareholderSep 18 '26Proposed Sale$39.19367,60014,406,2440
Savage BrianInterim Chief Legal OfficerSep 18 '26Option Exercise$34.704,503156,25415,842
Savage BrianInterim Chief Legal OfficerSep 18 '26Sale$38.857,342285,2158,500
MIGNONE ROBERTODirectorSep 18 '26Sale$39.06367,60014,356,8020
Savage BrianOfficerSep 18 '26Proposed Sale$38.857,028273,0620
Weiss AmirChief Accounting OfficerAug 21 '26Sale$37.629,445355,30113,071
Weiss AmirChief Accounting OfficerAug 21 '26Option Exercise$19.612,50049,02515,571
Satchi-Fainaro RonitDirectorAug 21 '26Sale$37.2541515,459111,986
Lippman EvanOfficerAug 17 '26Proposed Sale$36.5718,600680,2910
Lippman EvanEVP, Business DevelopmentAug 17 '26Sale$36.5718,600680,29125,591

Teva Pharmaceutical Industries Ltd Adr 주식(TEVA)의 최신 뉴스

Oct 30, 2026
Oct 30, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 27, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 25, 2026
Oct 25, 2026
Oct 24, 2026
Oct 24, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 22, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 19, 2026
Oct 18, 2026
Oct 18, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026

TEVA와(과) 유사한 종목